Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Targeting metabolic reprogramming in SWI/SNF-mutant cancers
EF 2022-23
Résumé
Genes, short regions of DNA, contain the instructions for a cell to grow and do its job. Within a cell, large molecules called remodelling complexes turn genes on or off and limit what set of instructions the cell can access. This system separates the shape and function of one kind of cell from another. One remodelling complex called the SWI/SNF complex consists of three types, each made with shared and unique complex members. In many cancers, the genes that make these SWI/SNF proteins are often mutated. These mutations change the behaviour of the complex in cancers and impact cell growth. Recently, we discovered that when all three SWI/SNF complexes are non-functional, ovarian and lung cancer cells have reduced glucose uptake and rely on glutamine and oxidative phosphorylation for energy production. This change can be a source of weakness in these cancer cells because drugs that damage this pathway can be used as potential treatments.
To follow up on our discovery, we want to see if the loss of one type of SWI/SNF complex is enough to cause glutamine and oxidative phosphorylation dependency or if the lack of all three groups is required to see this effect. We will test this by adding drugs that impair steps in either oxidative phosphorylation or glutamine metabolism to two groups of cells: cancer cells missing protein components of one of the three SWI/SNF complexes or cancer cells with fully functional complexes. Cell death in the former can tell us that these cancer cells rely more on this pathway to grow compared to the latter. This study will not only help understand how cancer cells choose their energy supply but also identify cancer patients that may benefit from the same treatment as those with cancers missing all SWI/SNF complex types.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486322
Name
Ho Rebecca
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Targeting metabolic reprogramming in SWI/SNF-mutant cancers
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Gynecologic Cancer; Metabolic Shifts And Vulnerabilities; Mouse Xenograft Cancer Models; Swi/Snf Deficient Cancers; Tissue Microarray
Abstract
Genes, short regions of DNA, contain the instructions for a cell to grow and do its job. Within a cell, large molecules called remodelling complexes turn genes on or off and limit what set of instructions the cell can access. This system separates the shape and function of one kind of cell from another. One remodelling complex called the SWI/SNF complex consists of three types, each made with shared and unique complex members. In many cancers, the genes that make these SWI/SNF proteins are often mutated. These mutations change the behaviour of the complex in cancers and impact cell growth. Recently, we discovered that when all three SWI/SNF complexes are non-functional, ovarian and lung cancer cells have reduced glucose uptake and rely on glutamine and oxidative phosphorylation for energy production. This change can be a source of weakness in these cancer cells because drugs that damage this pathway can be used as potential treatments.
To follow up on our discovery, we want to see if the loss of one type of SWI/SNF complex is enough to cause glutamine and oxidative phosphorylation dependency or if the lack of all three groups is required to see this effect. We will test this by adding drugs that impair steps in either oxidative phosphorylation or glutamine metabolism to two groups of cells: cancer cells missing protein components of one of the three SWI/SNF complexes or cancer cells with fully functional complexes. Cell death in the former can tell us that these cancer cells rely more on this pathway to grow compared to the latter. This study will not only help understand how cancer cells choose their energy supply but also identify cancer patients that may benefit from the same treatment as those with cancers missing all SWI/SNF complex types.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ho, Rebecca
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~